These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 35008229)
1. Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review. Zhao Z; Zhu A; Bhardwaj M; Schrotz-King P; Brenner H Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008229 [TBL] [Abstract][Full Text] [Related]
2. Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations. Yu H; Guan Z; Cuk K; Zhang Y; Brenner H Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30909610 [TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer. Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624 [TBL] [Abstract][Full Text] [Related]
4. A Fecal MicroRNA Signature by Small RNA Sequencing Accurately Distinguishes Colorectal Cancers: Results From a Multicenter Study. Pardini B; Ferrero G; Tarallo S; Gallo G; Francavilla A; Licheri N; Trompetto M; Clerico G; Senore C; Peyre S; Vymetalkova V; Vodickova L; Liska V; Vycital O; Levy M; Macinga P; Hucl T; Budinska E; Vodicka P; Cordero F; Naccarati A Gastroenterology; 2023 Sep; 165(3):582-599.e8. PubMed ID: 37263306 [TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Diagnostic Performance of Circulating MicroRNAs in Colorectal Cancer Detection with a Focus on Early-Onset Colorectal Cancer. AlZaabi A; Shalaby A Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273512 [TBL] [Abstract][Full Text] [Related]
6. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433 [TBL] [Abstract][Full Text] [Related]
7. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514 [TBL] [Abstract][Full Text] [Related]
8. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis. Iannone A; Losurdo G; Pricci M; Girardi B; Massaro A; Principi M; Barone M; Ierardi E; Di Leo A J Gastrointest Cancer; 2016 Jun; 47(2):143-51. PubMed ID: 26922358 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774 [TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA biomarkers for lung cancer detection in Western populations. Yu H; Guan Z; Cuk K; Brenner H; Zhang Y Cancer Med; 2018 Oct; 7(10):4849-4862. PubMed ID: 30259714 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review. Xue J; Jia E; Ren N; Lindsay A; Yu H Onco Targets Ther; 2019; 12():6665-6684. PubMed ID: 31692495 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of Fecal MicroRNAs for Colorectal Cancer: a Meta-Analysis. Wang C; Zhao K; Rong Q Clin Lab; 2015; 61(12):1845-53. PubMed ID: 26882806 [TBL] [Abstract][Full Text] [Related]
13. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer. Luo X; Wu Y; Ji M; Zhang S Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212 [TBL] [Abstract][Full Text] [Related]
14. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis. Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545 [TBL] [Abstract][Full Text] [Related]
15. Screening for colon cancer: A test for occult blood. Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687 [TBL] [Abstract][Full Text] [Related]
16. Fecal immunochemical test for hemoglobin in combination with fecal transferrin in colorectal cancer screening. Gies A; Cuk K; Schrotz-King P; Brenner H United European Gastroenterol J; 2018 Oct; 6(8):1223-1231. PubMed ID: 30288285 [TBL] [Abstract][Full Text] [Related]
17. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests. Meklin J; SyrjÄnen K; Eskelinen M Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599 [TBL] [Abstract][Full Text] [Related]
18. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review. Raut JR; Guan Z; Schrotz-King P; Brenner H Clin Epigenetics; 2020 Aug; 12(1):122. PubMed ID: 32778176 [TBL] [Abstract][Full Text] [Related]
19. Noninvasive fecal testing for colorectal cancer. Zou J; Xiao Z; Wu Y; Yang J; Cui N Clin Chim Acta; 2022 Jan; 524():123-131. PubMed ID: 34756863 [TBL] [Abstract][Full Text] [Related]